26.10.2012 - Temasek puts Medreich stake on the block
Temasek Holdings has appointed NM Rothschild to exit a seven-year-old investment in contract drug maker Medreich, which could attract offers from strategic investors like Blackstone-owned Catalent Pharma Solutions and Perrigo Company besides private equity investors. Temasek with about 30% stake expects Medreich to be valued at $200-250 million. "While Rothschild has been appointed by Temasek, we know that the promoters of the company may also look for an exit if the valuation expectations are met. It is a potential sellout, but the key is valuation," said people familiar with process...............................................Full Article: Source
Print